Biodexa Pharmaceuticals Plc Files 2024 Annual Report
Ticker: BDRX · Form: 20-F · Filed: Apr 11, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 20-F |
| Filed Date | Apr 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 20-F, pharmaceuticals
TL;DR
Biodexa dropped its 2024 20-F, check financials for the pharma company.
AI Summary
Biodexa Pharmaceuticals Plc filed its annual report on Form 20-F for the fiscal year ending December 31, 2024. The company, formerly known as Midatech Pharma Plc, is based in Cardiff, UK, and operates in the pharmaceutical preparations sector. The filing details its financial position and business operations for the reporting period.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Biodexa's financial performance and strategic direction for the past fiscal year, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Biodexa faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in a 20-F filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-04-11 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Biodexa Pharmaceuticals Plc (company) — Filer of the 20-F report
- Midatech Pharma Plc (company) — Former name of Biodexa Pharmaceuticals Plc
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-04-11 (date) — Filing date of the 20-F
- Cardiff, UK (location) — Company's business and mailing address
FAQ
What were Biodexa Pharmaceuticals Plc's total revenues for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is the company's primary business activity as stated in the 20-F?
The company's Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
When did Biodexa Pharmaceuticals Plc change its name from Midatech Pharma Plc?
The date of the name change from Midatech Pharma Plc to Biodexa Pharmaceuticals Plc was June 2, 2015.
What is the company's principal executive office address?
The business address is listed as 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ.
What is the SEC file number for Biodexa Pharmaceuticals Plc?
The SEC file number is 001-37652.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 11, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).